Mirjam E. van Albada

617 total citations
16 papers, 401 citations indexed

About

Mirjam E. van Albada is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mirjam E. van Albada has authored 16 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mirjam E. van Albada's work include Pulmonary Hypertension Research and Treatments (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers) and Cardiovascular Issues in Pregnancy (3 papers). Mirjam E. van Albada is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers) and Cardiovascular Issues in Pregnancy (3 papers). Mirjam E. van Albada collaborates with scholars based in Netherlands, Germany and United Kingdom. Mirjam E. van Albada's co-authors include Rolf M.F. Berger, Regien G. Schoemaker, Richard van Veghel, Marcus T.R. Roofthooft, Beatrijs Bartelds, A.H. Cromme-Dijkhuis, Mariska Kemna, Michael G. Dickinson, Adri H. Cromme-Dijkhuis and Janny Takens and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and European Journal of Pharmacology.

In The Last Decade

Mirjam E. van Albada

14 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirjam E. van Albada Netherlands 11 280 171 92 67 63 16 401
Diederik E. van der Feen Netherlands 10 286 1.0× 180 1.1× 101 1.1× 55 0.8× 139 2.2× 16 435
Naqiang Lv China 12 262 0.9× 110 0.6× 38 0.4× 74 1.1× 46 0.7× 40 419
Deyu Zheng China 15 405 1.4× 98 0.6× 35 0.4× 93 1.4× 88 1.4× 33 563
Hasan Güven Türkiye 6 265 0.9× 272 1.6× 145 1.6× 85 1.3× 162 2.6× 12 515
Takashi Iwakiri Japan 14 130 0.5× 81 0.5× 42 0.5× 74 1.1× 89 1.4× 20 408
Melanie Nies United States 11 288 1.0× 131 0.8× 82 0.9× 115 1.7× 53 0.8× 29 364
Xi-Qi Xu China 10 195 0.7× 179 1.0× 36 0.4× 45 0.7× 123 2.0× 28 392
Ole Knudson United States 9 94 0.3× 261 1.5× 96 1.0× 74 1.1× 47 0.7× 13 404
Jacob Marsvin Laurberg Denmark 5 123 0.4× 103 0.6× 27 0.3× 94 1.4× 46 0.7× 5 319
Masaaki Lee‐Kawabata Japan 13 67 0.2× 267 1.6× 56 0.6× 86 1.3× 39 0.6× 21 397

Countries citing papers authored by Mirjam E. van Albada

Since Specialization
Citations

This map shows the geographic impact of Mirjam E. van Albada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam E. van Albada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam E. van Albada more than expected).

Fields of papers citing papers by Mirjam E. van Albada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam E. van Albada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam E. van Albada. The network helps show where Mirjam E. van Albada may publish in the future.

Co-authorship network of co-authors of Mirjam E. van Albada

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam E. van Albada. A scholar is included among the top collaborators of Mirjam E. van Albada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam E. van Albada. Mirjam E. van Albada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Albada, Mirjam E. van, Pratik Shah, Terry G. J. Derks, et al.. (2023). Abnormal glucose homeostasis and fasting intolerance in patients with congenital porto-systemic shunts. Frontiers in Endocrinology. 14. 1190473–1190473. 2 indexed citations
2.
Albada, Mirjam E. van, Klaus Mohnike, Mark J. Dunne, Indraneel Banerjee, & Stephen F. Betz. (2022). Somatostatin receptors in congenital hyperinsulinism: Biology to bedside. Frontiers in Endocrinology. 13. 921357–921357. 5 indexed citations
3.
Mooij, Christiaan F., Carline E. Tacke, Mirjam E. van Albada, et al.. (2021). Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation. Annals of Pediatric Endocrinology & Metabolism. 26(4). 278–283. 6 indexed citations
4.
Wassenberg, Tessa, Jaap Deinum, Frans J. van Ittersum, et al.. (2020). Clinical presentation and long‐term follow‐up of dopamine beta hydroxylase deficiency. Journal of Inherited Metabolic Disease. 44(3). 554–565. 11 indexed citations
5.
Schönbeck, Yvonne, H.J. van der Kamp, Erica L T van den Akker, et al.. (2019). Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia. Archives of Disease in Childhood. 104(7). 653–657. 19 indexed citations
6.
Albada, Mirjam E. van, Klaus Mohnike, Henrik Thybo Christesen, et al.. (2017). A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism. Hormone Research in Paediatrics. 89(2). 82–89. 31 indexed citations
7.
Bartelds, Beatrijs, Rosa Laura E. van Loon, Michael G. Dickinson, et al.. (2011). Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension. CHEST Journal. 141(3). 651–660. 59 indexed citations
8.
Albada, Mirjam E. van, Beatrijs Bartelds, Michael G. Dickinson, et al.. (2009). Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions. American Journal of Physiology-Lung Cellular and Molecular Physiology. 298(4). L483–L491. 34 indexed citations
9.
Albada, Mirjam E. van & Rolf M.F. Berger. (2008). Pulmonary arterial hypertension in congenital cardiac disease – the need for refinement of the Evian-Venice classification. Cardiology in the Young. 18(1). 10–17. 40 indexed citations
10.
Albada, Mirjam E. van, et al.. (2008). Biological Serum Markers in the Management of Pediatric Pulmonary Arterial Hypertension. Pediatric Research. 63(3). 321–327. 78 indexed citations
11.
Albada, Mirjam E. van, et al.. (2007). Effects of erythropoietin on advanced pulmonary vascular remodelling. European Respiratory Journal. 31(1). 126–134. 21 indexed citations
12.
Albada, Mirjam E. van, Regien G. Schoemaker, & Rudolphus Berger. (2007). 354: Effects of bosentan on both pulmonary vascular remodeling and cardiac function and remodeling in pulmonary hypertension. The Journal of Heart and Lung Transplantation. 26(2). S187–S187.
13.
Albada, Mirjam E. van, Rudolphus Berger, & Regien G. Schoemaker. (2007). 523: Erythropoietin reverses pulmonary vascular remodelling in experimental flow-associated pulmonary hypertension. The Journal of Heart and Lung Transplantation. 26(2). S248–S248.
14.
Albada, Mirjam E. van, et al.. (2006). Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension. European Journal of Pharmacology. 549(1-3). 107–116. 26 indexed citations
15.
Albada, Mirjam E. van, Richard van Veghel, Adri H. Cromme-Dijkhuis, Regien G. Schoemaker, & Rolf M.F. Berger. (2006). Treprostinil in Advanced Experimental Pulmonary Hypertension: Beneficial Outcome Without Reversed Pulmonary Vascular Remodeling. Journal of Cardiovascular Pharmacology. 48(5). 249–254. 12 indexed citations
16.
Albada, Mirjam E. van, Regien G. Schoemaker, Mariska Kemna, et al.. (2005). The role of increased pulmonary blood flow in pulmonary arterial hypertension. European Respiratory Journal. 26(3). 487–493. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diederik E. van der Feen Breakdown of academic impact, for papers by Naqiang Lv Breakdown of academic impact, for papers by Deyu Zheng Breakdown of academic impact, for papers by Hasan Güven Breakdown of academic impact, for papers by Takashi Iwakiri Breakdown of academic impact, for papers by Melanie Nies Breakdown of academic impact, for papers by Xi-Qi Xu Breakdown of academic impact, for papers by Ole Knudson Breakdown of academic impact, for papers by Jacob Marsvin Laurberg Breakdown of academic impact, for papers by Masaaki Lee‐Kawabata
Rankless by CCL
2026